DexTradePoint

DexTradePoint is a forex and CFD broker that was established on 30 October 2024. According to its registration records, the company is incorporated in Saint Vincent and the Grenadines, a jurisdiction known for minimal regulatory requirements for financial service providers. The broker lists its registered address at 2 St Saviours Wharf, 23-25 Mill Street, London SE1 2BE, though this does not imply UK regulation.

At the time of FXCanary's review, DexTradePoint does not hold any licence from a recognised financial regulator. This absence of regulatory oversight is a significant factor for traders to consider, as it means the broker is not required to meet standard safety measures such as client fund segregation or participation in compensation schemes.

DexTradePoint offers five account tiers designed to accommodate different capital levels and trading preferences. The Micro Account requires a minimum deposit of $100 and offers leverage up to 1:500, targeting entry-level traders. The Uniglobe Premium account starts at $500 with 1:200 leverage, while the ECN Classic account requires $1,000 with 1:200 leverage. For higher-capital clients, the ECN Elite account demands $10,000 (1:100 leverage) and the Uniglobe VIP account requires $50,000 (1:100 leverage).

The range of leverage options, from conservative 1:100 to aggressive 1:500, suggests flexibility for various risk appetites. However, the lack of published information on instruments, spreads, commissions, or trading platforms means potential clients have limited data to evaluate the actual trading environment. The broker's website, hosted at dextradepoint.top, does not appear to provide comprehensive details on these aspects.

As a Saint Vincent and the Grenadines entity, DexTradePoint is not subject to the oversight of any major financial regulator such as the FCA, CySEC, or ASIC. The jurisdiction does not require forex brokers to obtain a licence to offer trading services, nor does it mandate compliance with international standards for client protection.

This regulatory vacuum means that traders who choose to open an account with DexTradePoint do so without the safeguards typically associated with regulated brokers. There is no assurance of negative balance protection, no access to an ombudsman or compensation fund, and no external audit of the broker's financial practices. FXCanary's risk assessment assigns a score of 60 out of 100, indicating an elevated risk profile that warrants caution.

Based on the account structure, DexTradePoint appears to target both retail traders with smaller capital ($100 Micro Account) and high-net-worth individuals ($50,000 VIP account). The varying leverage levels suggest the broker aims to accommodate different trading styles, from scalpers to long-term position traders.

However, the lack of regulatory oversight and the broker's recent establishment (less than a year old) make it a particularly risky choice for unsophisticated traders. The higher-risk accounts with 1:500 leverage, while attractive to those seeking large returns, could lead to rapid losses. Without verified regulatory protection, clients may have little recourse in disputes.

FXCanary's research has been limited by the scarcity of independent information about DexTradePoint. The broker's website does not appear to offer detailed disclosures concerning trading conditions, company leadership, or financial statements. The registered address in London is shared with many other firms and may serve as a virtual office, which is common among offshore brokers.

Prospective clients are strongly encouraged to conduct thorough due diligence before depositing funds. Verification of the broker's claims regarding execution speed, liquidity providers, and custody of client money is impossible without transparent reporting. The elevated risk score of 60/100 reflects this information gap.